[] Gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are the most commonly reported adverse effects
Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)
Theres excitement again around looking in the mirror and finally feeling like progress is happening
The peptide itself promotes angiogenesis through VEGFR2 signaling
For individuals who are highly sensitive to medication changes, this strategy could make treatment more tolerable and sustainable
Estrogen and the Male Hippocampus: Genetic Variation in the Aromatase Gene Predicting Serum Estrogen Is Associated with Hippocampal Gray Matter Volume in Men. Hippocampus, vol